This website uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Further information

TOLERANCE
Loading...

Vionnet, Julien


Publications

Impact Factor

Cites


ReferenceImpact FactorCitesQuartile
Thomson AW, Vionnet J, Sanchez-Fueyo A. Understanding, predicting and achieving liver transplant tolerance: from bench to bedside. Nat Rev Gastroenterol Hepatol. 2020 Aug 5. doi: 10.1038/s41575-020-0334-4. [Epub ahead of print] Review. PubMed PMID: 32759983.
29.869
54
1
Vionnet J, Sánchez-Fueyo A. Biomarkers of immune tolerance in liver transplantation. Hum Immunol. 2018 May;79(5):388-394. doi: 10.1016/j.humimm.2018.02.010. Epub 2018 Feb 17. Review. PubMed PMID: 29462637.
2.412
27
3
Vionnet J, Miquel R, Abraldes JG, Wall J, Kodela E, Lozano JJ, Ruiz P, Navasa M, Marshall A, Nevens F, Gelson W, Leithead J, Masson S, Jaeckel E, Taubert R, Tachtatzis P, Eurich D, Simpson KJ, Bonaccorsi-Riani E, Feng S, Bucuvalas J, Ferguson J, Quaglia A, Sidorova J, Elstad M, Douiri A, Sánchez-Fueyo A. Non-invasive alloimmune risk stratification of long-term liver transplant recipients. J Hepatol. 2021 Aug 23. pii: S0168-8278(21)02001-8. doi: 10.1016/j.jhep.2021.08.007. [Epub ahead of print] PubMed PMID: 34437910.
20.582
20
Vionnet J, Sempoux C, Pascual M, Sánchez-Fueyo A, Colmenero J. Donor-specific antibodies in liver transplantation. Gastroenterol Hepatol. 2020 Jan;43(1):34-45. doi: 10.1016/j.gastrohep.2019.09.010. Epub 2019 Dec 4. Review. English, Spanish. PubMed PMID: 31810796.
1.581
13
4
Appenzeller-Herzog C, Hartleif S, Vionnet J. Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: A scoping review. Am J Transplant. 2021 Mar 30. doi: 10.1111/ajt.16585. [Epub ahead of print] PubMed PMID: 33783969.
7.338
12
Appenzeller-Herzog C, Rosat A, Mathes T, Baroja-Mazo A, Chruscinski A, Feng S, Herrero I, Londono MC, Mazariegos G, Ohe H, Pons JA, Sanchez-Fueyo A, Waki K, Vionnet J. Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis. Liver Int. 2023 Oct 31. doi: 10.1111/liv.15764. Online ahead of print. PubMed PMID: 37905605.
6.7
0
Appenzeller-Herzog C, Rosat A, Mathes T, Baroja-Mazo A, Chruscinski A, Feng S, Herrero I, Londono MC, Mazariegos G, Ohe H, Pons JA, Sanchez-Fueyo A, Waki K, Vionnet J. Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis. Liver Int. 2023 Oct 31. doi: 10.1111/liv.15764. Online ahead of print. PubMed PMID: 37905605.
6.7
0
Appenzeller-Herzog C, Rosat A, Mathes T, Baroja-Mazo A, Chruscinski A, Feng S, Herrero I, Londono MC, Mazariegos G, Ohe H, Pons JA, Sanchez-Fueyo A, Waki K, Vionnet J. Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis. Liver Int. 2023 Oct 31. doi: 10.1111/liv.15764. Online ahead of print. PubMed PMID: 37905605.
6.7
0
Appenzeller-Herzog C, Rosat A, Mathes T, Baroja-Mazo A, Chruscinski A, Feng S, Herrero I, Londono MC, Mazariegos G, Ohe H, Pons JA, Sanchez-Fueyo A, Waki K, Vionnet J. Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis. Liver Int. 2023 Oct 31. doi: 10.1111/liv.15764. Online ahead of print. PubMed PMID: 37905605.
6.7
0
Vionnet J, Sanchez-Fueyo A. Biomarkers of operational tolerance after liver transplantation: are we there yet? Liver Transpl. 2021 Aug 18. doi: 10.1002/lt.26270. [Epub ahead of print] PubMed PMID: 34407265.
4.57
0
Vionnet J, Torres-Yaguana J, Miquel R, Abraldes JG, Wall J, Kodela E, Lozano JJ, Ruiz P, Navasa M, Marshall A, Nevens F, Gelson W, Leithead J, Masson S, Jaeckel E, Taubert R, Tachtatzis P, Eurich D, Simpson KJ, Bonaccorsi-Riani E, Ferguson J, Quaglia A, Demetris AJ, Lesniak AJ, Elstad M, Delord M, Douiri A, Rebollo-Mesa I, Martinez-Llordella M, Silva JAF, Markmann JF, Sanchez-Fueyo A. Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppression. Am J Transplant. 2024 Dec 18:S1600-6135(24)00749-4. doi: 10.1016/j.ajt.2024.12.002. Online ahead of print. PubMed PMID: 39706366.
8.9
Appenzeller-Herzog C, Hartleif S, Vionnet J. Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: a scoping review protocol. Version 3. F1000Res. 2019 Dec 5 [revised 2020 Jan 1];8:2059. doi: 10.12688/f1000research.21501.3. eCollection 2019. PubMed PMID: 32399186; PubMed Central PMCID: PMC7194345.3.
2.202
Vionnet J, Miquel R, Abraldes JG, Lozano JJ, Ruiz P, Navasa M, Marshall A, Nevens F, Gelson W, Leithead J, Masson S, Jaeckel E, Taubert R, Tachtatzis P, Eurich D, Simpson K, Bonaccorsi-Riani E, Ferguson J, Quaglia A, Elstad M, Delord M, Douiri A, Sanchez-Fueyo A. The clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation: the LIFT prospective RCT. Southampton (UK): National Institute for Health and Care Research; 2025 Apr. Available from http://www.ncbi.nlm.nih.gov/books/NBK613563/ PubMed PMID: 40238953.
2.0
Elsabbagh AM, Hadjiyannis Y, Vionnet J, Thomson AW. Clinical and Experimental Immune Tolerance in Pediatric Liver Transplantation. Pediatr Transplant. 2026 Jan;30(1):e70260. doi: 10.1111/petr.70260. PubMed PMID: 41500616.
1.4

Data Sources

PubMed
NCBI
SemanticScholar
Web of Science
Human Phenotype ontology
KEGG
IMIB-Arrixaca

Address

Biomedical Informatics & Bioinformatics Platform
Institute for Bio-health Research of Murcia (IMIB-Arrixaca)
Carretera Buenavista s/n, 30120
El Palmar, Murcia, Spain

E-mail

Phones

+34 968885229
+34 968885239
+34 968885249

Advanced Charts